Published in Endokrynol Pol on January 01, 1986
Incidentally discovered adrenal tumors: a lesson from observation of 1,444 patients. Horm Metab Res (2008) 1.10
Adrenocortical carcinoma. A clinical study and treatment results of 52 patients. Cancer (1995) 0.98
Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction. Atherosclerosis (1989) 0.86
The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome. J Endocrinol Invest (1991) 0.83
Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease. J Intern Med (1995) 0.78
The role of sex hormones in the mechanism of inhibited LH release in female patients with anorexia nervosa. Acta Endocrinol (Copenh) (1982) 0.78
Comment of long-acting lanreotide inducing clinical and biochemical remission of acromegaly caused by disseminated GHRH secreting carcinoid. J Clin Endocrinol Metab (1999) 0.77
Enhanced testosterone in female patients with anorexia nervosa: its normalization after weight gain. Acta Endocrinol (Copenh) (1979) 0.77
Cytostatics for acromegaly. Marked improvement in a patient with an invasive pituitary tumour. Acta Endocrinol (Copenh) (1987) 0.77
Antidiuretic effect of sulfonylureas in idiopathic diabetes insipidus. Helv Med Acta (1969) 0.76
Enhancement of plasma corticotropin-releasing hormone in pregnancy-induced hypertension. Acta Endocrinol (Copenh) (1990) 0.76
Radioimmunological determination of exogenous corticotropin-releasing hormone (CRH) and growth hormone-releasing hormone (GHRH): plasma half-life of CRH and GHRH. Endokrynol Pol (1989) 0.76
Incidentally found adrenal tumours: results of investigation of the pituitary-adrenal axis. Endokrynol Pol (1992) 0.75
The effect of oral ethanol ingestion on the diurnal neurotensin secretion in man. Endokrynol Pol (1992) 0.75
[Hyperaldosteronism after metoclopramide administration]. Pol Arch Med Wewn (1980) 0.75
[Assessment of the function of the hypothalamo-hypophyseal axis in patients with uncontrolled liver cirrhosis. I. Effect of exogenous thyreoliberin (TRH)]. Pol Arch Med Wewn (1982) 0.75
[Hypothyroidism and pregnancy]. Pol Tyg Lek (1986) 0.75
[Sex hormones in men with coronary arteriosclerosis]. Pol Tyg Lek (1991) 0.75
Decreased melatonin concentration in Cushing's syndrome. Horm Metab Res (1989) 0.75
Effects of transdermal 17 beta-oestradiol combined with oral progestogen on lipids and lipoproteins in hypercholesterolaemic postmenopausal women. J Intern Med (1993) 0.75
[Effect of calcitonin on the secretion of PRL, TSH, GH, LH, FSH, cortisol, T3 and T4]. Endokrynol Pol (1984) 0.75
[Alcohol decreases the alpha subunit, LH and testosterone secretion in response to LH-RH]. Endokrynol Pol (1992) 0.75
[Increased reverse triiodothyronine concentration in anorexia nervosa]. Endokrynol Pol (1981) 0.75
[Prolactin secretion in pituitary tumors and in galactorrhea syndrome]. Endokrynol Pol (1979) 0.75
[Hormonal changes in prostatic hypertrophy and cancer]. Endokrynol Pol (1982) 0.75
The effect of D-Trp6-LRH upon secretion of gonadotrophin--a possible therapeutic application in anorexia nervosa. Acta Endocrinol (Copenh) (1984) 0.75
Location of parathyroid adenomas by ultrasonography. Endokrynol Pol (1986) 0.75
[Ocular hydrodynamics in patients with infiltrative-edematous exophthalmos in Graves' disease]. Klin Oczna (1990) 0.75
[Studies on the pathogenesis of arterial hypertension in acromegaly. I. The renin-angiotensin-aldosterone system]. Pol Arch Med Wewn (1983) 0.75
[Analysis of calcitonin level in the diagnosis and evaluation of the results of the treatment of medullary carcinoma of the thyroid gland]. Pol Tyg Lek (1990) 0.75
[The beneficial effects of growth hormone replacement therapy on elderly men]. Pol Merkur Lekarski (1999) 0.75
[Role of the renin-angiotensin system in the etiology of hypertension in Cushing's syndrome]. Pol Arch Med Wewn (1981) 0.75
[Postprandial determination of growth hormone (GH) in the serum in response to TRH. A new test in the diagnosis of active acromegaly and gigantism]. Pol Arch Med Wewn (1979) 0.75
[Hypophyseal adenoma with markedly increased prolactin secretion]. Pol Arch Med Wewn (1978) 0.75
[Uncoupling of the renin-angiotensin-aldosterone system in Cushing's syndrome]. Endokrynol Pol (1982) 0.75
[The influence of testosterone replacement therapy on well-being, bone mineral density and lipids in elderly men]. Pol Arch Med Wewn (1998) 0.75
Evidence for alpha-adrenergic receptors mediated TSH release in men. Acta Endocrinol (Copenh) (1980) 0.75
Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report. Mater Med Pol (1982) 0.75
[Treatment of the malignant phase of infiltrative-edematous exophthalmos in Graves-Basedow disease]. Pol Tyg Lek (1985) 0.75
[The hypothalamo-hypophyseal-gonadal system in men with myocardial infarction]. Endokrynol Pol (1987) 0.75
Radioimmunological determination of beta-endorphin-like substance in human blood plasma and urine. Endokrynol Pol (1986) 0.75
Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue. Nuklearmedizin (1979) 0.75
The effect of a single dose of ethanol on melatonin secretion in women. Endokrynol Pol (1987) 0.75
[Hormonal replacement therapy in women after surgery for thyroid cancer treated with suppressive doses of L-thyroxine]. Wiad Lek (2001) 0.75
[Effect of metoclopramide and acth on aldosterone secretion in patients with insufficiency of the anterior pituitary gland]. Pol Arch Med Wewn (1985) 0.75
[Long-term inhibition of growth hormone secretion after alcohol intake. Disorders of physiological diurnal rhythm]. Pol Tyg Lek (1985) 0.75
[Role of hormonal disorders in the etiology of polycystic ovary syndrome (Stein-Leventhal syndrome)]. Endokrynol Pol (1982) 0.75
Polish consensus: procedure in case of estrogen deficiency in women after breast cancer therapy. Gynecol Endocrinol (2002) 0.75
[Hypogonadotropinemia in women with Cushing's syndrome]. Endokrynol Pol (1980) 0.75
Increased plasma VIP concentration in patients with prolactinoma. Endokrynol Pol (1992) 0.75
[Differential diagnosis of hypercalcemic crisis associated with hypokalemia, adenoma of the parathyroid, thyroid adenomatosis, thyrotoxicosis and arterial hypertension treated with hydrochlorothiazide]. Pol Tyg Lek (1987) 0.75
[Effect of prednisolone on triiodothyronine and thyroxine concentration in hyperthyroidism]. Pol Arch Med Wewn (1978) 0.75
[Cushing's syndrome: metyrapone therapy as a preparation for selective trans-sphenoidal adenomectomy]. Endokrynol Pol (1982) 0.75
The role of computed tomography in the localization of adrenal cortex tumors. Nuklearmedizin (1982) 0.75
[Intraocular pressure in patients with infiltrative-edematous exophthalmos in Graves' disease treated with prednisone]. Klin Oczna (1990) 0.75
[MEN 2A syndrome: report of a family]. Pol Merkur Lekarski (2000) 0.75
TRH-induced growth hormone release in insulin-dependent diabetes mellitus. Horm Metab Res (1984) 0.75
The effect of naloxone on the secretion of pituitary hormones in patients with acromegaly, microprolactinomas, Cushing's disease and Nelson's syndrome. Endokrynol Pol (1986) 0.75
[Optimal treatment of hyperactive "hot" thyroid nodules with radioactive iodine (I-131)]. Endokrynol Pol (1987) 0.75
The circadian rhythm of melatonin in hypothyroidism and hyperthyroidism. Acta Endocrinol (Copenh) (1988) 0.75
[Diurnal rhythm of prolactin secretion after excessive intake of alcohol]. Endokrynol Pol (1984) 0.75
Polycystic ovary syndrome, accompanied by autonomous prolactin hypersecretion. Case report. Ginekol Pol (1982) 0.75
Methodologic basis for the radioimmunoassay of endogenous LH-like activity in human prostatic tissue. Nuklearmedizin (1983) 0.75
Mixed pituitary tumours--effects of bromocriptine treatment: Parlodel MR and Parlodel LAR. Endokrynol Pol (1992) 0.75
[Diurnal rhythm of thyrotropin secretion in healthy women and in patients with primary hypothyroidism]. Endokrynol Pol (1983) 0.75
[Diurnal rhythm of prolactin secretion in women with primary hypothyroidism]. Endokrynol Pol (1984) 0.75
Growth hormone (GH) secretion during nocturnal sleep and after clonidine in patients with essential hypertension. Clin Exp Hypertens A (1988) 0.75
Thyrotropin-releasing hormone (TRH) does not suppress growth hormone response to L-dopa in insulin-dependent diabetes mellitus. Endokrynol Pol (1992) 0.75
[Scintigraphic and clinical evaluation of the surgical treatment of latent differentiated cancer of the thyroid]. Pol Tyg Lek (1982) 0.75
Lower 24-hour growth hormone levels in type I diabetics responding to thyrotropin-releasing hormone (TRH). Endokrynol Pol (1992) 0.75
Clinical applications of radioimmunoassay of the alpha-subunit of glycoprotein hormones. Endokrynol Pol (1992) 0.75
[Studies on the pathogenesis of arterial hypertension in acromegaly. II. Disorders of prolactin secretion]. Pol Arch Med Wewn (1983) 0.75
[Effect of synthetic LH-RH on gonadotropin secretion: LH and FSH in women with Addison's disease]. Endokrynol Pol (1980) 0.75
[Inhibition of growth hormone (GH) response to GHRH in diabetes mellitus type 1 after blockade of the cholinergic system with pirenzepine]. Pol Arch Med Wewn (1992) 0.75
[Ectopic production of parathyroid hormone (PTH) by malignant tumors]. Endokrynol Pol (1982) 0.75
[The effect of growth hormone replacement therapy on markers of bone formation and bone mineral density in elderly men]. Pol Arch Med Wewn (1998) 0.75
[Dissociation of the renin-angiotensin-aldosterone system in hyperthyroidism]. Pol Tyg Lek (1985) 0.75
New long-acting bromocriptine (Parlodel MR and Parlodel LAR) in the treatment of pituitary tumours with hyperprolactinemia. Endokrynol Pol (1992) 0.75
Growth hormone response to a low dose dopamine infusion in type I diabetics. Endokrynol Pol (1988) 0.75
[Pregnancy in women with thyroid cancer treated with suppressive doses of L-thyroxine]. Wiad Lek (2001) 0.75
[Results of treatment of hirsutism with spironolactone]. Endokrynol Pol (1982) 0.75
Plasma concentrations of atrial natriuretic hormone in acromegaly: relationship to hypertension. Acta Endocrinol (Copenh) (1991) 0.75
[Arterial hypertension in acromegaly]. Pol Arch Med Wewn (1987) 0.75
Prostatectomy--induced decrease in an enhanced serum testosterone concentration in patients with prostatic hyperplasia and its pathophysiological implications. Endokrynol Pol (1979) 0.75
[Circadian rhythm of prolactin release in women and men]. Endokrynol Pol (1982) 0.75
[Effect of hypercalcemia on the secretion of insulin and anterior pituitary hormones]. Endokrynol Pol (1984) 0.75
[Prolactin secretion in patients with hyperthyroidism]. Pol Tyg Lek (1985) 0.75
[Thyroid function in patients with decompensated liver cirrhosis]. Endokrynol Pol (1982) 0.75
Increased activity of digoxin-like substance in low-renin hypertension in acromegaly. Clin Exp Hypertens A (1990) 0.75
[Ocular hypertension in patients with infiltrative-edematous exophthalmos in Graves' disease]. Klin Oczna (1990) 0.75
[Attempt at diagnosis of pituitary microadenomas as a cause of spontaneous hyperprolactinemia]. Endokrynol Pol (1981) 0.75
[Different hypogonadism mechanism in men and women suffering from Cushing's disease]. Endokrynol Pol (1981) 0.75
[Relationship between clinical classification of hyperthyroidism for three grades of severity and level of triiodothyronine (T3) and thyroxine (T4) concentrations in serum]. Endokrynol Pol (1992) 0.75
Arterial hypertension in acromegaly: altered dopaminergic control of aldosterone secretion. Clin Exp Hypertens A (1987) 0.75
[Correlations between the secretory function of pituitary tumors and arterial hypertension in acromegaly]. Endokrynol Pol (1987) 0.75
High blood pressure and hyperinsulinaemia in acromegaly and in obesity. Clin Exp Hypertens A (1989) 0.75
[Physiological rhythm of triiodothyronine secretion]. Endokrynol Pol (1979) 0.75